The impact of changing oedematous states on the QRS duration: Implications for cardiac resynchronization therapy and implantable cardioverter/defibrillator implantation

Europace

Volumn 7, Issue 2, 2005, Pages 158-164

  Madias, John E ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b ELMHURST HOSPITAL CENTER   (United States)

Author keywords

Anasarca; Cardiac resynchronization therapy; Congestive heart failure; ECG; Implantable cardiology defibrillator; Low voltage ECG; Peripheral oedema; QRS duration

Indexed keywords

BODY WEIGHT; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC KIDNEY FAILURE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DETERIORATION; EDITORIAL; FOLLOW UP; HEART BUNDLE BRANCH BLOCK; HEART FAILURE; HEMODIALYSIS PATIENT; HUMAN; PATIENT REFERRAL; PERIPHERAL EDEMA; PRIORITY JOURNAL; QRS COMPLEX;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; EDEMA; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 14844320475     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eupc.2004.12.009     Document Type: Editorial

References (34)

1. Hewlett-Packard Interpretive Cardiograph. Physician's Guide. HP Part No. M1700-92908, Edition 4, Printed in USA September 1994. p. 7-1, C-1
2. P.W. Macfarlane T.D. Vetch Lawrie Comprehensive electrocardiology 1989 Pergamon New York p. 140, 417, 440, 450, 1147, 1442, 1603, 1651
3. D.M. Mirvis Electrocardiography. A physiologic approach 1993 Mosby St Louis p. 138, 283, 304
4. G.S. Wagner Marriott's practical electrocardiography 9th ed 1994 Williams and Wilkins Baltimore p. 15, 41, 42
5. M.I. Dunn B.S. Lipman Lipman-Massie clinical electrocardiography 7th ed 1984 Year Book Medical Publishers Chicago 146
6. M.E. Silverman M.D. Pressel J.C. Brackett et al., Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy Am J Cardiol 75 1995 460-464
7. M.R. Bristow A.M. Feldman L.A. Saxon for the COMPANION Steering Committee and Companion Clinical Investigators Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial J Cardiac Fail 6 2000 276-285
8. D.A. Kass C.-H. Chen C. Curry et al., Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay Circulation 99 1999 1567-1573
9. L.A. Saxon U.N. Kumar T. De Marco Heart failure and cardiac resynchronization therapies: U.S. experience in the year 2000 Ann Noninv Electrocardiol 5 2000 188-194
10. C. Stellbrink A. Auricchio B. Diem et al., Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia [Abstract] Am J Cardiol 83 1999 143D-150D
11. A. Auricchio C. Stellbrink S. Sack et al., The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: Rationale, design and endpoints of a prospective randomized multicenter study [Abstract] Am J Cardiol 83 1999 130D-135D
12. A. Auricchio H. Klein B. Tockman et al., Transvenous biventricular pacing for heart failure: Can the obstacles be overcome? [Abstract] Am J Cardiol 83 1999 136D-142D
13. W. Shamim D.P. Francis M. Yousuffuddin et al., Intraventricular conduction delay: A prognostic marker in chronic heart failure Int J Cardiol 70 1999 171-178
14. J.M. Aranda R.S. Schofield D. Leach et al., Ventricular dyssynchrony in dilated cardiomyopathy: The role of biventricular pacing in the treatment of congestive heart failure Clin Cardiol 25 2002 357-362
15. W. Shamim M. Yousufuddin M. Cicoria et al., Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure Heart 88 2002 47-51
16. A. Moss W. Zareba W.J. Hall et al., Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877-883
17. G. Gregoratos J. Abrams A.E. Epstein et al., ACC/AHA/NASPE2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/ NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106 2002 2145-2161
18. D.W. Romhilt K.E. Bove R.J. Norris et al., A critical appraisal of the electrocardiographic criteria for the diagnosis of left ventricular hypertrophy Circulation 40 1969 185-195
19. B. Pitt F. Zannad W.J. Remme et al., The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study investigators N Engl J Med 341 1999 709-717
20. M.G. St John Sutton T. Plappert W.T. Abraham et al., Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985-1990
21. S.A. Hunt D.W. Baker M.H. Chin et al., ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) developed in collaboration with the International Society for Heart and Lung Transplantation endorsed by the Heart Failure Society of America J Am Coll Cardiol 38 2001 2101-2113
22. S. Cazeau C. Leclercq T. Lavergne et al., Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873-880
23. W.T. Abraham W.G. Fisher A.L. Smith for MIRACLE study group et al., Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845-1853
24. J.M. Aranda E.R. Carlson D.F. Pauly et al., QRS duration variability in patients with heart failure Am J Cardiol 90 2002 335-337
25. D. Notabartolo J.D. Merlino A.L. Smith et al., Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy Am J Cardiol 94 2004 817-820
26. F. Philippon Cardiac resynchronization therapy: Device-based medicine for heart failure J Card Surg 19 2004 270-274
27. L.E. Sade H. Kanzaki D. Severyn et al., Quantification of radial mechanical dyssynchrony in patients with left bundle branch block and idiopathic dilated cardiomyopathy without conduction delay by tissue displacement imaging Am J Cardiol 94 2004 514-518
28. D.A. Brody A theoretical analysis of intracavitary blood mass influence on the electrocardiogram Circ Res 4 1956 731-738
29. Y. Rudy R. Plonsey Comments on the effects of variations in the size of the heart on the magnitude of ECG potentials J Electrocardiol 13 1980 79-82
30. J.E. Madias Significance of shortening of the mean QRS duration of the standard electrocardiogram in patients developing peripheral edema Am J Cardiol 89 2002 1444-1446
31. J.E. Madias R. Bazaz H. Agarwal et al., Anasarca-mediated attenuation of the amplitude of ECG complexes: A description of a heretofore unrecognized phenomenon J Am Coll Cardiol 38 2001 756-764
32. J.E. Madias H. Agarwal M. Win et al., Effect of weight loss in congestive heart failure from idiopathic dilated cardiomyopathy on electrocardiographic QRS voltage Am J Cardiol 89 2002 86-88
33. J.E. Madias S. Attanti V. Narayan Relationship among electrocardiographic potential amplitude, weight, and resistance/ reactance/impedance in a patient with peripheral edema treated for congestive heart failure J Electrocardiol 36 2003 167-171
34. J.E. Madias V. Narayan Augmentation of the amplitude of electrocardiographic QRS complexes immediately following hemodialysis: A study of 26 hemodialysis sessions of a single patient, aided by measurements of resistance/reactance/impedance J Electrocardiol 36 2003 263-271